Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
FHLC
322
HOLDINGS
6%
ALSO IN MEDX
MEDX
28
HOLDINGS
68%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus MEDX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.4% | 18.1% | 9.4% |
|
ABBVIE INC | 6.0% | 9.2% | 6.0% |
|
JOHNSON & JOHNSON | 6.9% | 5.0% | 5.0% |
|
MERCK & CO. INC. | 3.4% | 3.3% | 3.3% |
|
AMGEN INC | 2.4% | 4.1% | 2.4% |
FHLC Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 4.7% |
|
ABBOTT LABORATORIES | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.0% |
|
INTUITIVE SURGICAL INC | 2.7% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
|
GILEAD SCIENCES INC | 2.3% |
|
STRYKER CORP | 2.2% |
|
DANAHER CORP | 2.1% |
 |
MEDTRONIC PLC | 1.9% |
|
JOHNSON & JOHNSON | 1.9% |
FHLC Underweight Relative to MEDX
|
ELI LILLY & CO | -8.7% |
 |
NOVARTIS AG-ADR | -6.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.3% |
|
IONIS PHARMACEUTICALS, INC. | -4.7% |
|
ALNYLAM PHARMACEUTICALS INC | -4.6% |
|
ALKERMES PLC | -3.3% |
|
ABBVIE INC | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
BIOGEN IDEC INC | -2.5% |